Adage Capital Partners Gp, L.L.C. Wave Life Sciences Ltd. Transaction History

Adage Capital Partners Gp, L.L.C.

$52.3 Billion
Q2 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,357,719 shares of WVE stock, worth $44.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,357,719

Previous 5,201,389 3.01%

Holding current value

$44.4 Million

Previous $32.1 Million 16.69%

% of portfolio

0.05%

Previous 0.06%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.38 - $6.48 $684,725 - $1.01 Million	156,330 Added 3.01%	5,357,719 $26.7 Million
Q1 2024 May 15, 2024	SELL	$3.54 - $6.84 $2.78 Million - $5.38 Million	-786,341 Reduced 13.13%	5,201,389 $32.1 Million
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $9.15 Million - $15.1 Million	2,200,000 Added 58.08%	5,987,730 $30.2 Million
Q3 2023 Nov 14, 2023	SELL	$3.56 - $5.75 $2.96 Million - $4.78 Million	-831,179 Reduced 18.0%	3,787,730 $21.8 Million
Q1 2023 May 15, 2023	SELL	$3.58 - $6.3 $3.25 Million - $5.72 Million	-907,975 Reduced 16.43%	4,618,909 $20 Million
Q4 2022 Feb 14, 2023	BUY	$3.18 - $7.0 $13.1 Million - $28.9 Million	4,125,495 Added 294.39%	5,526,884 $38.7 Million
Q3 2022 Nov 14, 2022	SELL	$2.37 - $4.28 $3.19 Million - $5.76 Million	-1,345,752 Reduced 48.99%	1,401,389 $5.06 Million
Q2 2022 Aug 15, 2022	BUY	$1.23 - $3.25 $2.83 Million - $7.47 Million	2,297,141 Added 510.48%	2,747,141 $8.93 Million
Q4 2021 Feb 14, 2022	BUY	$3.14 - $5.15 $157,000 - $257,500	50,000 Added 12.5%	450,000 $1.41 Million
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.12 $1.96 Million - $2.85 Million	400,000 New	400,000 $1.96 Million

Others Institutions Holding WVE

# of Institutions

146

Shares Held

93.1M

Call Options Held

33K

Put Options Held

57.2K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $720M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Wave Life Sciences Ltd. Transaction History